This inventor holds 3 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Kevin Edward Burdon Parkes: Innovator in Pharmaceutical Research
Introduction
Kevin Edward Burdon Parkes is a notable inventor based in Letchworth, GB. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target viral infections. With a total of 3 patents, his work has the potential to impact the treatment of serious health conditions.
Latest Patents
One of Parkes' latest patents is focused on inhibitors of the HPV E1 helicase enzyme. This invention involves novel benzodiazepine derivatives, a process for their manufacture, pharmaceutical compositions, and the use of these compounds in medicine. The compounds are specifically designed to inhibit the human papillomavirus E1 helicase enzyme, which plays a crucial role in viral replication. As a result, these compounds may serve as therapeutic agents for HPV-mediated diseases.
Another significant patent by Parkes is related to anti-HIV pyrazole derivatives. This invention also concerns novel pyrazole derivatives, their manufacturing process, pharmaceutical compositions, and their application in medicine. The compounds developed under this patent are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme, which is essential for viral replication. Consequently, these compounds may be effectively used as therapeutic agents for HIV-mediated processes.
Career Highlights
Kevin Edward Burdon Parkes is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this organization has allowed him to focus on innovative solutions for viral infections, contributing to the advancement of medical science.
Collaborations
Throughout his career, Parkes has collaborated with esteemed colleagues, including Philip Stephen Jones and Martin John Parratt. These collaborations have fostered a productive environment for research and development in the pharmaceutical sector.
Conclusion
Kevin Edward Burdon Parkes is a distinguished inventor whose work in pharmaceutical research has led to the development of innovative compounds targeting viral infections. His contributions are poised to make a significant impact on the treatment of HPV and HIV-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile